These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20384600)

  • 1. Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
    Hunter AM; Leuchter AF; Cook IA; Abrams M
    Acta Psychiatr Scand; 2010 Dec; 122(6):461-9. PubMed ID: 20384600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does prior antidepressant treatment of major depression impact brain function during current treatment?
    Hunter AM; Cook IA; Leuchter AF
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
    Hunter AM; Muthén BO; Cook IA; Leuchter AF
    J Psychiatr Res; 2010 Jan; 44(2):90-8. PubMed ID: 19631948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain function of depressed subjects during treatment with placebo.
    Leuchter AF; Cook IA; Witte EA; Morgan M; Abrams M
    Am J Psychiatry; 2002 Jan; 159(1):122-9. PubMed ID: 11772700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?
    Hunter AM; Cook IA; Abrams M; Leuchter AF
    Med Hypotheses; 2013 Dec; 81(6):1004-11. PubMed ID: 24112999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain function during administration of venlafaxine or placebo to normal subjects.
    Leuchter AF; Cook IA; DeBrota DJ; Hunter AM; Potter WZ; McGrouther CC; Morgan ML; Abrams M; Siegman B
    Clin EEG Neurosci; 2008 Oct; 39(4):175-81. PubMed ID: 19044214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in prefrontal activity characterize clinical responders to antidepressants.
    Cook IA; Leuchter AF; Morgan M; Witte E; Stubbeman WF; Abrams M; Rosenberg S; Uijtdehaage SH
    Neuropsychopharmacology; 2002 Jul; 27(1):120-31. PubMed ID: 12062912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midline and right frontal brain function as a physiologic biomarker of remission in major depression.
    Cook IA; Hunter AM; Abrams M; Siegman B; Leuchter AF
    Psychiatry Res; 2009 Nov; 174(2):152-7. PubMed ID: 19853417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
    Hunter AM; Leuchter AF; Morgan ML; Cook IA
    Am J Psychiatry; 2006 Aug; 163(8):1426-32. PubMed ID: 16877657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.
    Tourian KA; Padmanabhan K; Groark J; Ninan PT
    J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder.
    de la Salle S; Jaworska N; Blier P; Smith D; Knott V
    Psychiatry Res Neuroimaging; 2020 Aug; 302():111109. PubMed ID: 32480044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.